Literature DB >> 12456202

Health state preference assessment in diabetic peripheral neuropathy.

Sean D Sullivan1, Doris P Lew, E Beth Devine, Zafar Hakim, Gayle E Reiber, David L Veenstra.   

Abstract

OBJECTIVE: To assess patient preferences for health states associated with diabetic peripheral neuropathy (DPN). DESIGN AND INTERVENTION: Seven health states describing varying stages of disease severity in DPN were developed: mild neuropathy, painful neuropathy, severe neuropathy, minor ulcer, severe ulcer, minor amputation and major amputation. Using a computer interview, both rating scale (RS) and standard gamble (SG) preference scores were elicited from 52 patients with diabetes mellitus.
SETTING: A US university medical centre and a Veterans Affairs clinic. STUDY PARTICIPANTS: Adult patients with type 1 and type 2 diabetes mellitus between the ages of 18 and 80 years. Patients were excluded if they had been diagnosed with DPN.
RESULTS: Preference scores decreased in accordance with greater symptomatic and functional impairment. Median RS scores ranged from 0.89 to 0.23 for the seven health states. Median SG scores ranged from 0.96 to 0.65.
CONCLUSIONS: Patient preferences for health states decrease as a function of increasing disease severity in DPN. The result is robust across the RS and SG methods of preference measurement. These results may be useful in informing policy analyses for resource allocation in patients with diabetes mellitus.

Entities:  

Mesh:

Year:  2002        PMID: 12456202     DOI: 10.2165/00019053-200220150-00004

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  14 in total

Review 1.  Methods for quality adjustment of life years.

Authors:  E Nord
Journal:  Soc Sci Med       Date:  1992-03       Impact factor: 4.634

2.  Automated utility assessment of global health.

Authors:  R F Nease; R Tsai; L M Hynes; B Littenberg
Journal:  Qual Life Res       Date:  1996-02       Impact factor: 4.147

3.  Methodology for measuring health-state preferences--II: Scaling methods.

Authors:  D G Froberg; R L Kane
Journal:  J Clin Epidemiol       Date:  1989       Impact factor: 6.437

4.  Psychological status of diabetic people with or without lower limb disability.

Authors:  A L Carrington; S K Mawdsley; M Morley; J Kincey; A J Boulton
Journal:  Diabetes Res Clin Pract       Date:  1996-04       Impact factor: 5.602

5.  Long-term functional status and quality of life after lower extremity revascularization.

Authors:  J Holtzman; M Caldwell; C Walvatne; R Kane
Journal:  J Vasc Surg       Date:  1999-03       Impact factor: 4.268

6.  Symptoms of sensory neuropathy in adults with NIDDM in the U.S. population.

Authors:  M Harris; R Eastman; C Cowie
Journal:  Diabetes Care       Date:  1993-11       Impact factor: 19.112

7.  Comparison of the rating scale and the standard gamble in measuring patient preferences for outcomes of gallstone disease.

Authors:  E B Bass; E P Steinberg; H A Pitt; R I Griffiths; K D Lillemoe; G P Saba; C Johns
Journal:  Med Decis Making       Date:  1994 Oct-Dec       Impact factor: 2.583

8.  Variation in patient utilities for outcomes of the management of chronic stable angina. Implications for clinical practice guidelines. Ischemic Heart Disease Patient Outcomes Research Team.

Authors:  R F Nease; T Kneeland; G T O'Connor; W Sumner; C Lumpkins; L Shaw; D Pryor; H C Sox
Journal:  JAMA       Date:  1995-04-19       Impact factor: 56.272

9.  The performance of three measures of health status in an outpatient diabetes population.

Authors:  M J Bardsley; S Astell; A McCallum; P D Home
Journal:  Diabet Med       Date:  1993 Aug-Sep       Impact factor: 4.359

10.  Quality of life issues in patients with diabetes and lower extremity ulcers: patients and care givers.

Authors:  M Brod
Journal:  Qual Life Res       Date:  1998-05       Impact factor: 4.147

View more
  9 in total

1.  Pregabalin for painful diabetic peripheral neuropathy.

Authors:  Lee C Rogers; David G Armstrong
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-11-18

Review 2.  A meta-analysis of health state valuations for people with diabetes: explaining the variation across methods and implications for economic evaluation.

Authors:  Tom W C Lung; Alison J Hayes; Andrew Hayen; Andrew Farmer; Philip M Clarke
Journal:  Qual Life Res       Date:  2011-04-07       Impact factor: 4.147

3.  Use of tricyclic antidepressants in older patients with painful neuropathies.

Authors:  Ariel Berger; Ellen M Dukes; John Edelsberg; Brett R Stacey; Gerry Oster
Journal:  Eur J Clin Pharmacol       Date:  2006-06-27       Impact factor: 2.953

4.  Utilities and disutilities for attributes of injectable treatments for type 2 diabetes.

Authors:  Kristina S Boye; Louis S Matza; Kimberly N Walter; Kate Van Brunt; Andrew C Palsgrove; Aodan Tynan
Journal:  Eur J Health Econ       Date:  2010-03-12

5.  Accounting for the development of antibacterial resistance in the cost effectiveness of ertapenem versus piperacillin/tazobactam in the treatment of diabetic foot infections in the UK.

Authors:  Jeroen P Jansen; Ritesh Kumar; Yehuda Carmeli
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

6.  Variation in treatment preferences and care goals among older patients with diabetes and their physicians.

Authors:  Marshall H Chin; Melinda L Drum; Lei Jin; Morgan E Shook; Elbert S Huang; David O Meltzer
Journal:  Med Care       Date:  2008-03       Impact factor: 2.983

7.  Utilities and disutilities for type 2 diabetes treatment-related attributes.

Authors:  Louis S Matza; Kristina S Boye; Nicole Yurgin; Jessica Brewster-Jordan; Sally Mannix; Jodi M Shorr; Beth L Barber
Journal:  Qual Life Res       Date:  2007-07-19       Impact factor: 4.147

8.  Decreased health-related quality of life in patients with diabetic foot problems.

Authors:  Jin Sothornwit; Gulapar Srisawasdi; Atchara Suwannakin; Apiradee Sriwijitkamol
Journal:  Diabetes Metab Syndr Obes       Date:  2018-03-07       Impact factor: 3.168

9.  Developing a Valuation Function for the Preference-Based Multiple Sclerosis Index: Comparison of Standard Gamble and Rating Scale.

Authors:  Ayse Kuspinar; Simon Pickard; Nancy E Mayo
Journal:  PLoS One       Date:  2016-04-28       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.